Literature DB >> 9572818

Muscle metabolites and performance during high-intensity, intermittent exercise.

M Hargreaves1, M J McKenna, D G Jenkins, S A Warmington, J L Li, R J Snow, M A Febbraio.   

Abstract

Six men were studied during four 30-s "all-out" exercise bouts on an air-braked cycle ergometer. The first three exercise bouts were separated by 4 min of passive recovery; after the third bout, subjects rested for 4 min, exercised for 30 min at 30-35% peak O2 consumption, and rested for a further 60 min before completing the fourth exercise bout. Peak power and total work were reduced (P < 0. 05) during bout 3 [765 +/- 60 (SE) W; 15.8 +/- 1.0 kJ] compared with bout 1 (1,168 +/- 55 W, 23.8 +/- 1.2 kJ), but no difference in exercise performance was observed between bouts 1 and 4 (1,094 +/- 64 W, 23.2 +/- 1.4 kJ). Before bout 3, muscle ATP, creatine phosphate (CP), glycogen, pH, and sarcoplasmic reticulum (SR) Ca2+ uptake were reduced, while muscle lactate and inosine 5'-monophosphate were increased. Muscle ATP and glycogen before bout 4 remained lower than values before bout 1 (P < 0.05), but there were no differences in muscle inosine 5'-monophosphate, lactate, pH, and SR Ca2+ uptake. Muscle CP levels before bout 4 had increased above resting levels. Consistent with the decline in muscle ATP were increases in hypoxanthine and inosine before bouts 3 and 4. The decline in exercise performance does not appear to be related to a reduction in muscle glycogen. Instead, it may be caused by reduced CP availability, increased H+ concentration, impairment in SR function, or some other fatigue-inducing agent.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9572818     DOI: 10.1152/jappl.1998.84.5.1687

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  28 in total

Review 1.  Interval training for performance: a scientific and empirical practice. Special recommendations for middle- and long-distance running. Part II: anaerobic interval training.

Authors:  L V Billat
Journal:  Sports Med       Date:  2001-02       Impact factor: 11.136

Review 2.  Long-term metabolic and skeletal muscle adaptations to short-sprint training: implications for sprint training and tapering.

Authors:  A Ross; M Leveritt
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

3.  Effect of Two Types of Active Recovery on Fatigue and Climbing Performance.

Authors:  Pedro L Valenzuela; Pedro de la Villa; Carmen Ferragut
Journal:  J Sports Sci Med       Date:  2015-11-24       Impact factor: 2.988

Review 4.  Evidence for complex system integration and dynamic neural regulation of skeletal muscle recruitment during exercise in humans.

Authors:  A St Clair Gibson; T D Noakes
Journal:  Br J Sports Med       Date:  2004-12       Impact factor: 13.800

5.  Influence of different rest intervals during active or passive recovery on repeated sprint swimming performance.

Authors:  Argyris G Toubekis; Helen T Douda; Savvas P Tokmakidis
Journal:  Eur J Appl Physiol       Date:  2004-11-20       Impact factor: 3.078

Review 6.  Physiological and metabolic responses of repeated-sprint activities:specific to field-based team sports.

Authors:  Matt Spencer; David Bishop; Brian Dawson; Carmel Goodman
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

Review 7.  Applied physiology of tennis performance.

Authors:  M S Kovacs
Journal:  Br J Sports Med       Date:  2006-05       Impact factor: 13.800

Review 8.  Tennis physiology: training the competitive athlete.

Authors:  Mark S Kovacs
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

Review 9.  Cardiac parasympathetic reactivation following exercise: implications for training prescription.

Authors:  Jamie Stanley; Jonathan M Peake; Martin Buchheit
Journal:  Sports Med       Date:  2013-12       Impact factor: 11.136

Review 10.  The measurement of maximal (anaerobic) power output on a cycle ergometer: a critical review.

Authors:  Tarak Driss; Henry Vandewalle
Journal:  Biomed Res Int       Date:  2013-08-29       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.